DEST — Destiny Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- £4.50m
- -£1.88m
Annual cashflow statement for Destiny Pharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.52 | -6.48 | -6.27 | -7.71 | -6.45 |
| Depreciation | |||||
| Non-Cash Items | 0.14 | 0.068 | 0.39 | 0.469 | 0.186 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.732 | 0.904 | 0.778 | 1.34 | 0.78 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.63 | -5.49 | -5.09 | -5.89 | -5.47 |
| Capital Expenditures | -0.021 | -2.26 | -0.03 | -0.001 | -0.081 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 5.06 | 0.072 | 0.016 | 0.065 | 0.29 |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 5.04 | -2.19 | -0.015 | 0.064 | 0.209 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0.007 | 9.95 | 0.007 | 6.09 | 6.74 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.419 | 2.26 | -5.1 | 0.258 | 1.48 |